Literature DB >> 20955963

Inborn errors of carbohydrate metabolism.

Ertan Mayatepek1, Björn Hoffmann, Thomas Meissner.   

Abstract

Glycogen storage diseases (GSD) and inborn errors of galactose and fructose metabolism are the most common representatives of inborn errors of carbohydrate metabolism. In this review the focus is set on the current knowledge about clinical symptoms, diagnosis and treatment. Hepatomegaly and hypoglycaemia are the main findings in liver-affecting GSD like type I, III and IX. Diagnosis is usually made by non invasive investigations, e.g. mutation analysis. In GSD I, a carbohydrate balanced diet with frequent meals and nocturnal continuous tube feeding or addition of uncooked corn starch are the mainstays of treatment to prevent hypoglycaemia. Liver transplantation has been performed in different types of GSD. It should only be considered in high risk patients e.g. with substantial cirrhosis. Many countries have included classical galactosaemia in their newborn screening programs. A lactose-free infant formula can be life-saving in affected neonates whereas a strict fructose-restricted diet is indicated in hereditary fructose intolerance.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20955963     DOI: 10.1016/j.bpg.2010.07.012

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  12 in total

Review 1.  An Introduction to Pharmacotherapy for Inborn Errors of Metabolism.

Authors:  Aaron A Harthan
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Nov-Dec

2.  Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia.

Authors:  Abrar Turki; Sylvia Stockler; Sandra Sirrs; Ramona Salvarinova; Gloria Ho; Jennifer Branov; Annie Rosen-Heath; Taryn Bosdet; Rajavel Elango
Journal:  Mol Genet Metab Rep       Date:  2022-05-11

3.  Glycogen storage disease type Ia: linkage of glucose, glycogen, lactic acid, triglyceride, and uric acid metabolism.

Authors:  Sakine Sever; David A Weinstein; Joseph I Wolfsdorf; Reyhan Gedik; Ernst J Schaefer
Journal:  J Clin Lipidol       Date:  2012-08-30       Impact factor: 4.766

4.  Case report on an infant presenting with hypoglycemia, and milky serum.

Authors:  Yogesh Kumar Gupta; Anushre Prasad; Pushpa Kini; Prashant Naik; Deepti Choprra; Krishnananda Prabhu
Journal:  Asian Pac J Trop Biomed       Date:  2012-04

5.  Evaluation of the effects of fructose on oxidative stress and inflammatory parameters in rat brain.

Authors:  Abigail Lopes; Thais Ceresér Vilela; Luciane Taschetto; Franciele Vuolo; Fabricia Petronilho; Felipe Dal-Pizzol; Emilio Luiz Streck; Gustavo Costa Ferreira; Patrícia Fernanda Schuck
Journal:  Mol Neurobiol       Date:  2014-04-02       Impact factor: 5.590

Review 6.  Neonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and Treatment.

Authors:  Thomas Götze; Holger Blessing; Christian Grillhösl; Patrick Gerner; André Hoerning
Journal:  Front Pediatr       Date:  2015-06-17       Impact factor: 3.418

7.  Allelic variation, aneuploidy, and nongenetic mechanisms suppress a monogenic trait in yeast.

Authors:  Amy Sirr; Gareth A Cromie; Eric W Jeffery; Teresa L Gilbert; Catherine L Ludlow; Adrian C Scott; Aimée M Dudley
Journal:  Genetics       Date:  2014-11-13       Impact factor: 4.562

8.  A new variant in PHKA2 is associated with glycogen storage disease type IXa.

Authors:  Carmen Rodríguez-Jiménez; Fernando Santos-Simarro; Ángel Campos-Barros; Carmen Camarena; Dolores Lledín; Elena Vallespín; Ángela Del Pozo; Rocío Mena; Pablo Lapunzina; Sonia Rodríguez-Nóvoa
Journal:  Mol Genet Metab Rep       Date:  2017-01-12

9.  Fructose: a key factor in the development of metabolic syndrome and hypertension.

Authors:  Zeid Khitan; Dong Hyun Kim
Journal:  J Nutr Metab       Date:  2013-05-25

10.  International practices in the dietary management of fructose 1-6 biphosphatase deficiency.

Authors:  A Pinto; M Alfadhel; R Akroyd; Y Atik Altınok; S M Bernabei; L Bernstein; G Bruni; G Caine; E Cameron; R Carruthers; B Cochrane; A Daly; F de Boer; S Delaunay; A Dianin; M Dixon; E Drogari; S Dubois; S Evans; J Gribben; G Gugelmo; C Heidenborg; I Hunjan; I L Kok; B Kumru; A Liguori; D Mayr; E Megdad; U Meyer; R B Oliveira; A Pal; A Pozzoli; R Pretese; J C Rocha; S Rosenbaum-Fabian; J Serrano-Nieto; E Sjoqvist; C Timmer; L White; T van den Hurk; M van Rijn; H Zweers; M Ziadlou; A MacDonald
Journal:  Orphanet J Rare Dis       Date:  2018-01-25       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.